|
1
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim H, Cho NH, Kim DS, et al:
Genitourinary Pathology Study Group of the Korean Society of
Pathologists: Renal cell carcinoma in south Korea: a multicenter
study. Hum Pathol. 35:1556–1563. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Prasad SR, Humphrey PA, Catena JR, et al:
Common and uncommon histologic subtypes of renal cell carcinoma:
imaging spectrum with pathologic correlation. Radiographics.
26:1795–1806. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Herman JG and Baylin SB: Gene silencing in
cancer in association with promoter hypermethylation. N Engl J Med.
349:2042–2054. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Taby RI and Issa JP: Cancer epigenetics.
CA Cancer J Clin. 60:376–92. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Balkwill F: Cancer and the chemokine
network. Nat Rev Cancer. 4:540–550. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Koizumi K, Hojo S, Akashi T, Yasumoto K
and Saiki I: Chemokine receptors in cancer metastasis and cancer
cell-derived chemokines in host immune response. Cancer Sci.
98:1652–1658. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
O'Hayre M, Salanga CL, Handel TM and Allen
SJ: Chemokines and cancer: migration, intracellular signalling and
intercellular communication in the microenvironment. Biochem J.
409:635–649. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Raport CJ, Gosling J, Schweickart VL, Gray
PW and Charo IF: Molecular cloning and functional characterization
of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1beta
and MIP-1alpha. J Biol Chem. 271:17161–17166. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Samson M, Labbe O, Mollereau C, Vassart G
and Parmentier M: Molecular cloning and functional expression of a
new human CC-chemokine receptor gene. Biochemistry. 35:3362–3367.
1996. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Spagnolo P, Renzoni EA, Wells AU, et al:
C-C chemokine receptor 5 gene variants in relation to lung disease
in sarcoidosis. Am J Respir Crit Care Med. 172:721–728. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Bibikova M, Lin Z, Zhou L, et al:
High-throughput DNA methylation profiling using universal bead
arrays. Genome Res. 16:383–393. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yoo KH, Park YK, Kim HS, Jung WW and Chang
SG: Epigenetic inactivation of HOXA5 and MSH2 gene in clear cell
renal cell carcinoma. Pathol Int. 60:661–666. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Herman JG, Graff JR, Myöhänen S, Nelkin BD
and Baylin SB: Methylation-specific PCR: a novel PCR assay for
methylation status of CpG islands. Proc Natl Acad Sci USA.
93:9821–9826. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Bibikova M, Lin Z, Zhou L, et al:
High-throughput DNA methylation profiling using universal bead
arrays. Genome Res. 16:383–393. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ehrlich M: DNA hypomethylation in cancer
cells. Epigenomics. 1:239–259. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ehrlich M: DNA methylation in cancer: too
much, but also too little. Oncogene. 21:5400–5413. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
de Capoa A, Musolino A, Della Rosa S, et
al: DNA demethylation is directly related to tumour progression:
evidence in normal, pre-malignant and malignant cells from uterine
cervix samples. Oncol Rep. 10:545–549. 2003.PubMed/NCBI
|
|
19
|
Brothman AR, Swanson G, Maxwell TM, et al:
Global hypomethylation is common in prostate cancer cells: a
quantitative predictor for clinical outcome? Cancer Genet
Cytogenet. 156:31–36. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Das PM and Singal R: DNA methylation and
cancer. J Clin Oncol. 22:4632–4642. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Kim YI, Giuliano A, Hatch KD, et al:
Global DNA hypomethylation increases progressively in cervical
dysplasia and carcinoma. Cancer. 74:893–899. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lin CH, Hsieh SY, Sheen IS, et al:
Genome-wide hypomethylation in hepatocellular carcinogenesis.
Cancer Res. 61:4238–4243. 2001.PubMed/NCBI
|
|
23
|
Bedford MT and van Helden PD:
Hypomethylation of DNA in pathological conditions of the human
prostate. Cancer Res. 47:5274–5276. 1987.PubMed/NCBI
|
|
24
|
Okano M, Bell DW, Haber DA and Li E: DNA
methyltransferases Dnmt3a and Dnmt3b are essential for de novo
methylation and mammalian development. Cell. 99:247–257. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Feinberg AP and Vogelstein B:
Hypomethylation of ras oncogenes in primary human cancers. Biochem
Biophys Res Commun. 111:47–54. 1983. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jürgens B, Schmitz-Dräger BJ and Schulz
WA: Hypomethylation of L1 LINE sequences prevailing in human
urothelial carcinoma. Cancer Res. 56:5698–5703. 1996.PubMed/NCBI
|
|
27
|
Zimmermann T, Moehler M, Gockel I, et al:
Low expression of chemokine receptor CCR5 in human colorectal
cancer correlates with lymphatic dissemination and reduced CD8+
T-cell infiltration. Int J Colorectal Dis. 25:417–424. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
van Deventer HW, O'Connor W Jr, Brickey
WJ, Aris RM, Ting JP and Serody JS: C-C chemokine receptor 5 on
stromal cells promotes pulmonary metastasis. Cancer Res.
65:3374–3379. 2005.PubMed/NCBI
|
|
29
|
Lin S, Wan S, Sun L, et al: Chemokine C-C
motif receptor 5 and C-C motif ligand 5 promote cancer cell
migration under hypoxia. Cancer Sci. 103:904–912. 2012. View Article : Google Scholar : PubMed/NCBI
|
